Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
International Journal of Sports Physiology and Performance|November 12, 2016
Prediction of Functional Overreaching From Subjective Fatigue and Readiness to Train After Only 3 Days of CyclingTwan Ten Haaf, Selma van Staveren, Erik Oudenhoven, et al.
International Journal of Sports Physiology and Performance|September 6, 2017
Changes in Choice Reaction Time During and After 8 Days Exhaustive Cycling Are Not Related to Changes in Physical PerformanceTwan Ten Haaf, Selma van Staveren, Danilo Iannetta, et al.
Minerva Chirurgica|June 26, 2001
[Splenectomy for hematologic disease. Mini-invasive versus traditional technique]E Monteferrante, A Giunta, L Bigi, et al.
ESMO Open|September 12, 2021
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patientsM Del Re, C Omarini, L Diodati, et al.
Arquivos Brasileiros De Cardiologia|February 7, 2001
Ventricular evoked response in patients with hypertrophic obstructive cardiomyopathy treated with DDD pacingJ R Sant'Anna, R Prati, H Hutten, et al.
Breast Cancer Research and Treatment|March 15, 2017
Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trialsM V Dieci, A Frassoldati, D Generali, et al.
Breast (Edinburgh, Scotland)|August 15, 2022
Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancerA Viansone, B Pellegrino, C Omarini, et al.
Plos One|October 31, 2018
Multi-dimensional flow cytometry analysis reveals increasing changes in the systemic neutrophil compartment during seven consecutive days of endurance exerciseSelma van Staveren, Twan Ten Haaf, Margot Klöpping, et al.
ESMO Open|February 14, 2021
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID eraA Toss, C Isca, M Venturelli, et al.
The Pharmacogenomics Journal|July 6, 2016
Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancerA Musolino, N Naldi, M V Dieci, et al.
Pageof 8